Envestnet Asset Management Inc United Therapeutics Corp Transaction History

Envestnet Asset Management Inc

  • $302 Billion
  • Q3 2024

A detailed history of Envestnet Asset Management Inc transactions in United Therapeutics Corp stock. As of the latest transaction made, Envestnet Asset Management Inc holds 57,991 shares of UTHR stock, worth $21.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
57,991
Previous 48,981 18.39%
Holding current value
$21.1 Million
Previous $15.6 Million 33.19%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024
BUY
$311.04 - $363.55 $2.8 Million - $3.28 Million
9,010 Added 18.39%
57,991 $20.8 Million
Q2 2024

Aug 08, 2024
BUY
$228.26 - $319.04 $1.26 Million - $1.76 Million
5,531 Added 12.73%
48,981 $15.6 Million
Q1 2024

May 13, 2024
SELL
$210.76 - $249.51 $528,796 - $626,020
-2,509 Reduced 5.46%
43,450 $9.98 Million
Q4 2023

Feb 13, 2024
BUY
$214.88 - $256.94 $90,464 - $108,171
421 Added 0.92%
45,959 $10.1 Million
Q3 2023

Nov 13, 2023
SELL
$211.82 - $248.24 $1.62 Million - $1.9 Million
-7,656 Reduced 14.39%
45,538 $10.3 Million
Q2 2023

Aug 04, 2023
SELL
$205.19 - $232.99 $99.1 Million - $113 Million
-482,990 Reduced 90.08%
53,194 $11.7 Million
Q1 2023

May 11, 2023
BUY
$212.99 - $276.17 $102 Million - $132 Million
477,636 Added 815.8%
536,184 $120 Million
Q4 2022

Feb 07, 2023
BUY
$205.95 - $280.43 $1.71 Million - $2.34 Million
8,327 Added 16.58%
58,548 $16.3 Million
Q3 2022

Nov 10, 2022
SELL
$203.3 - $244.17 $100,836 - $121,108
-496 Reduced 0.98%
50,221 $10.5 Million
Q2 2022

Aug 03, 2022
SELL
$174.81 - $241.14 $1.91 Million - $2.63 Million
-10,921 Reduced 17.72%
50,717 $12 Million
Q1 2022

May 04, 2022
BUY
$166.16 - $213.96 $346,942 - $446,748
2,088 Added 3.51%
61,638 $11.1 Million
Q4 2021

Feb 04, 2022
BUY
$184.32 - $216.08 $874,229 - $1.02 Million
4,743 Added 8.65%
59,550 $12.9 Million
Q3 2021

Oct 07, 2021
BUY
$179.86 - $214.88 $7.07 Million - $8.45 Million
39,325 Added 254.0%
54,807 $10.1 Million
Q2 2021

Aug 04, 2021
BUY
$170.47 - $211.93 $371,624 - $462,007
2,180 Added 16.39%
15,482 $2.78 Million
Q1 2021

May 04, 2021
BUY
$153.94 - $174.85 $407,479 - $462,827
2,647 Added 24.84%
13,302 $2.23 Million
Q4 2020

Feb 02, 2021
SELL
$101.87 - $151.79 $189,172 - $281,874
-1,857 Reduced 14.84%
10,655 $1.62 Million
Q3 2020

Oct 09, 2020
SELL
$99.9 - $121.13 $168,831 - $204,709
-1,690 Reduced 11.9%
12,512 $1.26 Million
Q2 2020

Jul 08, 2020
BUY
$92.74 - $125.82 $1.08 Million - $1.47 Million
11,652 Added 456.94%
14,202 $1.72 Million
Q1 2020

Apr 23, 2020
SELL
$79.39 - $115.35 $578,673 - $840,786
-7,289 Reduced 74.08%
2,550 $242,000
Q4 2019

Feb 11, 2020
BUY
$78.31 - $95.34 $68,442 - $83,327
874 Added 9.75%
9,839 $867,000
Q3 2019

Oct 17, 2019
BUY
$74.85 - $85.99 $139,445 - $160,199
1,863 Added 26.23%
8,965 $715,000
Q2 2019

Aug 02, 2019
BUY
$76.06 - $120.81 $17,493 - $27,786
230 Added 3.35%
7,102 $554,000
Q1 2019

May 10, 2019
BUY
$107.15 - $126.84 $456,351 - $540,211
4,259 Added 162.99%
6,872 $807,000
Q4 2018

Feb 13, 2019
BUY
$101.4 - $128.73 $264,958 - $336,371
2,613 New
2,613 $285,000
Q3 2018

Nov 14, 2018
SELL
$113.81 - $129.46 $97,535 - $110,947
-857 Closed
0 $0
Q2 2018

Aug 10, 2018
SELL
$101.14 - $118.31 $1,213 - $1,419
-12 Reduced 1.38%
857 $96,000
Q1 2018

May 09, 2018
SELL
$107.21 - $151.94 $15,009 - $21,271
-140 Reduced 13.88%
869 $97,000
Q4 2017

Feb 20, 2018
SELL
$118.58 - $151.28 $889,587 - $1.13 Million
-7,502 Reduced 88.14%
1,009 $149,000
Q3 2017

Nov 13, 2017
BUY
$114.6 - $136.81 $811,941 - $969,298
7,085 Added 496.84%
8,511 $997,000
Q2 2017

Aug 14, 2017
BUY
N/A
1,426
1,426 $182,000

Others Institutions Holding UTHR

# of Institutions
668
Shares Held
42.8M
Call Options Held
194K
Put Options Held
295K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.6B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email